NCT01777919View on ClinicalTrials.gov

Disulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma Multiform

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 31, 2027

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2030

Conditions
Glioblastoma Multiforme
Interventions
DRUG

Temozolomide

already included

DRUG

Disulfiram

already included

DRUG

Copper

already included

Trial Locations (1)

26443

Olympion Medical Center, Pátrai

All Listed Sponsors
collaborator

University of Ioannina

OTHER

collaborator

University of Eastern Finland

OTHER

collaborator

University of Ulm

OTHER

lead

Olympion Medical Center

OTHER